Ling Guo

Ling Guo

Auto-generated profile, based on publicly available information

Ling Guo

Affiliation Department of Infectious Diseases, Peking University Shenzhen hospital, Shenzhen, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Hepatology
Verified
Journal Article
Open access
YLYongyin Li
Yongyin Li
CWChunhua Wen
Chunhua Wen
SGShuqin Gu
Shuqin Gu
WWWeibin Wang
Weibin Wang
LGLing Guo
Ling Guo
JHJinlin Hou
Jinlin Hou
Export Background and Aims: Long-term maintenance of viral control, even HBsAg loss, remains a challenge for chronic hepatitis B (CHB) patients undergoing nucleos(t)ide analogue (NA) discontinuation. This study aimed to investigate the relationship between HBV-specific T cell responses targeting peptides spanning the whole proteome and clinical outcomes in CHB patients after NA discontinuation. Approach and Results: Eighty-eight CHB patients undergoing NA discontinuation were classified as responders (remained relapse-free up to 96 wk) or relapsers (relapsed patients who underwent NA re-treatment for up to 48 weeks and re-achieved stable viral control). HBV-specific T cell responses were detected at baseline and longitudinally throughout follow-up. We found responders had a greater magnitude of HBV Polymerase (Pol)-specific T cell responses than relapsers at baseline. After long-term NA discontinuation, simultaneously enhanced HBV Core- and Pol-induced responses were observed in responders. Particularly, responders with HBsAg loss possessed enhanced HBV Envelope (Env)-induced responses after short and long-term follow-up. Notably, CD4+T cells accounted for the predominance of HBV-specific T cell responses. Correspondingly, CD4-deficient mice showed attenuated HBV-specific CD8+T cell responses, reduced HBsAb-producing B cells, and delayed HBsAg loss; in contrast, in vitro addition of CD4+T cells promoted HBsAb production by B cells . Additionally, interleukin (IL)-9, rather than PD-1 blockade, enhanced HBV Pol-specific CD4+T cell responses. Conclusion: HBV-specific CD4+T cell responses induced by the targeted peptide possess specificities for long-term viral control and HBsAg loss in CHB patients undergoing NA discontinuation, indicating that CD4+T cells specific for distinct HBV antigens may endow with divergent antiviral potential.

9 September 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LDLu Dai
Lu Dai
JTJungang Tan
Jungang Tan
ZZZhimin Zhou
Zhimin Zhou
CCChengcong Chen
Chengcong Chen
GHGuoxin Hu
Guoxin Hu
LGLing Guo
Ling Guo
Background: Acute liver failure (ALF) is a serious clinical disease. Immune infiltration and oxidative stress (OS) play an important role in ALF, but the combination of oxidative stress and immune infiltration in ALF has not been explored. Methods: Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were performed on ALF and control samples in the GSE96851 dataset to obtain DE-OS-MGs. Candidate OS-IM-associated signature genes were mined using the least absolute shrinkage and selection operator (LASSO) and support vector machine (SVM) machine learning. Finally, OS-IM-related signature genes were obtained by expression analysis and ROC validation. Single gene set enrichment analysis (GSEA), TF-miRNA-mRNA network construction and drug prediction were also performed for OS-IM-related signature genes. Results: Differential analysis identified a total of 3580 DEGs in ALF and control samples, and differential analysis of immune cells yielded 15 immune cell species that were significantly different between the two groups. After WGCNA analysis, 1134 key module genes were screened. Then, 3580 DEGs, 855 OS-related genes, and 1134 key module genes were intersected, resulting in a total of 89 DE-OS-MGs. Furthermore, machine learning was performed and the genes were intersected to obtain 5 candidate OS-IM-related signature genes. The expression levels and ROC analysis of the 5 genes were validated in the GSE96851 and GSE120652 datasets, and 4 genes (CLU, APOH, AMBP, and GPX8) were used as biomarkers (OS-IM-related signature genes) for subsequent analysis. Single-gene GSEA enrichment analysis revealed that the 4 biomarkers were associated with metabolic processes. A miRNA-mRNA network with 123 nodes and 194 relationship pairs was obtained. 49 TFs of 3 biomarkers (APOH, AMBP, and GPX8) and 56 relationship pairs of TFs-mRNA regulatory network also constructed. Searching for therapeutic drugs of 4 biomarkers, a drug-mRNA network of CLU and 3 drugs was constructed. Conclusion: In this study, we combined immune infiltration landscape and oxidative stress based on bioinformatic analysis to screen for diagnostic markers (CLU, APOH, AMBP, and GPX8) of ALF. It provides a new idea and theoretical basis for the therapeutic diagnosis of ALF.